产品和服务 / 产品类型 / ELISA试剂盒 / ELISA 抗体对
This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.
* This package insert must be read in its entirety before using this product.
Human cTnI ELISA, Multiplex
| Recommended Concentration | Sample | ||
|---|---|---|---|
| ELISA | Capture | 1-4ug/mL | Rabbit anti-Human cTnI mAb (Cat. No. RM17655) |
| Detection | 0.03-0.1ug/mL | Rabbit anti-Human cTnI mAb (Cat. No. RM17654) | |
| Standard | 78-5000pg/mL | Nature Human cTnI Protein | |
| Multiplex | Capture | 6ug/106 | Rabbit anti-Human cTnI mAb (Cat. No. RM17653) |
| Detection | 0.25-1ug/ml | Rabbit anti-Human cTnI mAb (Cat. No. RM17654) | |
| Standard | 5.5-4000pg/mL | Nature Human cTnI Protein |
Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19.
